Redmile as of Dec. 31, 2016
Portfolio Holdings for Redmile
Redmile holds 50 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 12.6 | $146M | 17M | 8.79 | |
| Seattle Genetics | 6.9 | $80M | 1.5M | 52.77 | |
| Clovis Oncology | 6.2 | $72M | 1.6M | 44.42 | |
| Penumbra (PEN) | 5.7 | $66M | 1.0M | 63.80 | |
| Amicus Therapeutics (FOLD) | 5.3 | $61M | 12M | 4.97 | |
| Ariad Pharmaceuticals | 4.1 | $48M | 3.8M | 12.44 | |
| Incyte Corporation (INCY) | 3.9 | $45M | 452k | 100.27 | |
| Molina Healthcare (MOH) | 3.8 | $44M | 806k | 54.26 | |
| Gw Pharmaceuticals Plc ads | 3.5 | $41M | 366k | 111.75 | |
| Puma Biotechnology (PBYI) | 3.4 | $40M | 1.3M | 30.70 | |
| Atara Biotherapeutics (ATRA) | 3.3 | $38M | 2.7M | 14.20 | |
| Neuroderm Ltd F | 3.0 | $35M | 1.6M | 22.20 | |
| Prothena (PRTA) | 2.8 | $32M | 654k | 49.19 | |
| Agios Pharmaceuticals (AGIO) | 2.7 | $31M | 739k | 41.73 | |
| Centene Corporation (CNC) | 2.5 | $29M | 517k | 56.51 | |
| Xencor (XNCR) | 2.3 | $26M | 996k | 26.32 | |
| Oxford Immunotec Global | 2.2 | $25M | 1.7M | 14.95 | |
| Wave Life Sciences (WVE) | 2.1 | $25M | 952k | 26.15 | |
| Express Scripts Holding | 2.0 | $23M | 339k | 68.79 | |
| Nanostring Technologies (NSTGQ) | 1.8 | $21M | 938k | 22.30 | |
| Alder Biopharmaceuticals | 1.6 | $19M | 921k | 20.80 | |
| Nevro (NVRO) | 1.6 | $19M | 260k | 72.66 | |
| Charles River Laboratories (CRL) | 1.6 | $19M | 247k | 76.19 | |
| Chimerix (CMRX) | 1.3 | $15M | 3.3M | 4.60 | |
| Audentes Therapeutics | 1.3 | $15M | 833k | 18.27 | |
| Array Biopharma Inc note 3.000% 6/0 | 1.1 | $13M | 9.0M | 1.40 | |
| Patheon N V | 1.1 | $13M | 441k | 28.71 | |
| Syros Pharmaceuticals | 1.0 | $12M | 948k | 12.16 | |
| Anthem (ELV) | 1.0 | $11M | 77k | 143.77 | |
| eHealth (EHTH) | 0.9 | $11M | 998k | 10.65 | |
| Boston Scientific Corporation (BSX) | 0.9 | $9.9M | 460k | 21.63 | |
| Invitae (NVTAQ) | 0.7 | $8.5M | 1.1M | 7.94 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.7 | $7.7M | 1.6M | 4.90 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $7.7M | 697k | 10.99 | |
| Model N (MODN) | 0.6 | $7.2M | 810k | 8.85 | |
| Endologix | 0.6 | $6.9M | 1.2M | 5.72 | |
| Irhythm Technologies (IRTC) | 0.6 | $6.9M | 229k | 30.00 | |
| VCA Antech | 0.4 | $4.8M | 70k | 68.65 | |
| Spectranetics Corporation | 0.4 | $4.6M | 188k | 24.50 | |
| Global Blood Therapeutics In | 0.4 | $4.6M | 316k | 14.45 | |
| Dynavax Technologies (DVAX) | 0.4 | $4.1M | 1.0M | 3.95 | |
| Fate Therapeutics (FATE) | 0.3 | $3.6M | 1.4M | 2.51 | |
| Ra Pharmaceuticals | 0.2 | $2.7M | 180k | 15.19 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $2.6M | 94k | 27.14 | |
| Diplomat Pharmacy | 0.2 | $1.9M | 153k | 12.60 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.1 | $1.2M | 4.5k | 265.33 | |
| UnitedHealth (UNH) | 0.0 | $291k | 1.8k | 159.89 | |
| Aurinia Pharmaceuticals (AUPH) | 0.0 | $77k | 37k | 2.10 | |
| Adverum Biotechnologies | 0.0 | $64k | 22k | 2.88 | |
| Castlight Health | 0.0 | $51k | 10k | 4.99 |
